David P McLaughlin MD FACC
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Director Cardiac Cath Lab and Intervention Sentera RMH medical center
Join to View Full Profile
2006 Health Campus DrHarrisonburg, VA 22801
Phone+1 540-689-7400
Fax+1 757-963-9617
Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Interventional Cardiology, 2004 - 2005
University of Virginia Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1986 - 1990
Pennsylvania State University College of MedicineClass of 1986
Certifications & Licensure
VA State Medical License 1990 - 2026
ID State Medical License 2006 - 2007
MT State Medical License 2005 - 2007
NC State Medical License 2004 - 2006
PA State Medical License 1987 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 2 citationsThe contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing.Robert V. Kelly, Michael Gillespie, Mauricio G. Cohen, David P. McLaughlin, E. Magnus Ohman
Angiology. 2008-05-27 - 1 citationsRenal Fibromuscular DysplasiaDavid P. McLaughlin, Robert V. Kelly, R. A. Santa-Cruz, George A. Stouffer
Circulation. 2005-10-25 - 13 citationsHemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery diseaseDavid P. McLaughlin, George A. Beller, Joel Linden, Carlos R. Ayers, Marcia L. Ripley
The American Journal of Cardiology. 1994-06-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
